Delivery Order SPE2DR25D6044-SPE2DR26FYA4M
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of 500 tablets of Lisinopril-HCTZ 20-25 mg at a ceiling value of $4,598.58. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The order is scheduled for completion by December 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Lisinopril-HCTZ 20-25 mg tablets (500 count) with a ceiling value of $6,953.93 and ultimate completion date of December 10, 2025. This contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,297.30 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Lisinopril-Hydrochlorothiazide 20-25 mg, a combination antihypertensive medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on November 14, 2025, with an ultimate completion date of November 17, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for 1,000 units of the medication Lisinopril-HCTZ 20-25 mg tablets, with a potential value of $1,459.16. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is...
- The Defense Logistics Agency awarded a $1,248.47 delivery order to AmerisourceBergen Drug Corp for Lisinopril tablets, with an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The delivery order will be performed at AmerisourceBergen's corporate...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,088 units of Lisinopril-HCTZ 20-25 mg tablets, with a ceiling value of $1,027.91 and a period of performance through October 15, 2024. AmerisourceBergen has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by DLA and other agencies, including a $999,999,999 IDC with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of 1,000 tablets of Lisinopril 10 mg, valued at $1,563.72. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively bid. The contract is scheduled for ultimate completion on September 10, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Lisinopril is an ACE inhibitor...
- The Defense Logistics Agency awarded a delivery order valued at $4,131.97 to AmerisourceBergen Drug Corp for 1,000 tablets of Lisinopril 40 mg, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed price terms and represents a direct fulfillment order under AmerisourceBergen's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the drug Lisinopril-HCTZ 20-12.5 mg tablets, with a firm fixed price of $1,126.61 and a performance period through May 13, 2025. The contract is not set aside for any small business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a $24,220 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of 40mg lisinopril. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 18-19, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing Government-Wide Acquisition Contract vehicle or set-aside...
- SPE2DR25D6044Indefinite Delivery Contract
- SPE2DR25D6044-SPE2DR26FYA4MDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Lisinopril-HCTZ 20-25 mg tablets in a quantity of 500 units, with a ceiling value of $4,603.10. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and requires delivery by December 12, 2025, to the company's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. Through its DLA Troop Support Medical prime contract, the company supplies a broad range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies to support Defense Health Agency operations and other federal healthcare systems globally. This specific delivery order represents a routine pharmaceutical fulfillment under the prime contract's flexible vehicle structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 12/10/25 |